Insider · CIK 0001689739

Pershing Edward

Reports to the SEC for 1 company · KNOXVILLE, TN

sec.gov

Transactions

Companies

Filings

CIK

0001689739

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-23	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+7,599 sh	—	—	3,006,133
2026-10-23	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-10-10	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-10-10	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+22.6K sh	—	—	2,998,534
2026-10-03	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-10-03	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+13.2K sh	—	—	2,975,925
2026-09-18	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-09-18	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+13.2K sh	—	—	2,962,709
2026-09-11	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-09-11	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+13.2K sh	—	—	2,949,493
2026-09-04	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-09-04	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+11.3K sh	—	—	2,936,277
2026-08-26	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-08-26	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+11.3K sh	—	—	2,924,949
2026-06-30	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockA Award	Director, CEO, 10% Owner	AAward	+45.9K sh	—	—	2,866,761
2026-06-05	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-06-05	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+9,436 sh	—	—	2,857,285
2026-05-28	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-05-23	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-05-23	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+32.1K sh	—	—	2,847,849
2026-05-15	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-05-15	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+22.7K sh	—	—	2,815,760
2026-05-07	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-05-07	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+18.9K sh	—	—	2,793,109
2026-04-29	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-04-29	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+30.2K sh	—	—	2,774,233
2026-04-04	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-04-04	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+34K sh	—	—	2,744,031
2026-03-25	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-03-20	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-03-20	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+49.1K sh	—	—	2,710,054
2026-03-12	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-03-05	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-02-26	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-02-20	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-02-20	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+47.2K sh	—	—	2,660,987
2026-02-19	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-02-12	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-02-09	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockP Purchase	Director, CEO, 10% Owner	PPurchase	+34.9K sh	$2.86	+$100K	2,613,807
2026-02-05	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-01-30	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-01-30	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+37.7K sh	—	—	2,578,867
2026-01-28	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2026-01-16	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	—	—	—	—
2026-01-16	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · Series D-1 Convertible Preferred StockM Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+37.7K sh	—	—	2,541,123
2025-12-11	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2025-12-05	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2025-11-26	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2025-11-20	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—
2025-11-13	PVCTPROVECTUS BIOPHARMACEUTICALS, INC. · 8% Unsecured Convertible Promissory NoteA Award	Director, CEO, 10% Owner	AAward	—	—	—	—

Recent filings

Accepted (ET)
Oct 234
Pershing Edward0001493152-26-048321
SEC(opens sec.gov)
Oct 134
Pershing Edward0001493152-26-046701
SEC(opens sec.gov)
Oct 54
Pershing Edward0001493152-26-045713
SEC(opens sec.gov)
Sep 184
Pershing Edward0001493152-26-043276
SEC(opens sec.gov)
Sep 114
Pershing Edward0001493152-26-042331
SEC(opens sec.gov)
Sep 84
Pershing Edward0001493152-26-041727
SEC(opens sec.gov)
Aug 264
Pershing Edward0001493152-26-040207
SEC(opens sec.gov)
Jul 24
Pershing Edward0001493152-26-031718
SEC(opens sec.gov)
Jun 54
Pershing Edward0001493152-26-027467
SEC(opens sec.gov)
May 294
Pershing Edward0001493152-26-026269
SEC(opens sec.gov)
May 264
Pershing Edward0001493152-26-025188
SEC(opens sec.gov)

Companies

PROVECTUS BIOPHARMACEUTICALS, INC.Director, CEO, 10% OwnerPVCT

Address

800 S. GAY STREET, SUITE 1610

KNOXVILLE, TN, 37929